Merck Sharp & Dohme Corp. v. Sun Pharmaceutical Industries Ltd.

Application Number	Patent Number	External Links
-	US7326708	Espacenet Google Patents
-	US8414921	Espacenet Google Patents

COMPLAINT for PATENT INFRINGEMENT filed against Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2569962.) - filed by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(nmg) (Entered: 02/14/2019)

2019-02-13

1

View

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 02/14/2019)

2019-02-13

1

View

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: See Attached. (nmg) (Entered: 02/14/2019)

2019-02-13

1

View

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708; 8,414,921. (nmg) (Entered: 02/14/2019)

2019-02-13

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (nmg) (Entered: 02/14/2019)

2019-02-13

1

View

MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Shaun P. Mahaffy, Anthony H. Sheh, and Jingyuan Luo - filed by Merck Sharp & Dohme Corp.. (Attachments: # 1 Certifications)(Silver, Daniel) Modified on 2/22/2019 (nms). (Entered: 02/21/2019)

2019-02-21

1

View

DECLARATION of Mailing regarding service on Sun Pharma Global FZE made on February 14, 2019, by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibits A-B)(Silver, Daniel) Modified on 2/25/2019 (nms). (Entered: 02/25/2019)

2019-02-25

1

View

DECLARATION of Mailing regarding service on Sun Pharmaceutical Industries Ltd. made on February 14, 2019, by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibits A-B)(Silver, Daniel) Modified on 2/25/2019 (nms). (Entered: 02/25/2019)

2019-02-25

1

View

STIPULATION TO EXTEND TIME to move against, answer, or otherwise plead in response to the Complaint to April 10, 2019 - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.. (Gaza, Anne) (Entered: 03/07/2019)

2019-03-07

1

View

MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Claire A. Fundakowski and Zachary B. Cohen - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.. (Wilson, Samantha) (Entered: 03/15/2019)

2019-03-15

1

View

ANSWER to 1 Complaint, Affirmative Defenses, and COUNTERCLAIMS against Merck Sharp & Dohme Corp. by Sun Pharmaceutical Industries Ltd., Sun Pharma Global FZE.(Gaza, Anne) Modified on 4/10/2019 (nms). (Entered: 04/10/2019)

2019-04-10

1

View

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Industries Ltd. for Sun Pharma Global FZE filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.. (Wilson, Samantha) (Entered: 04/10/2019)

2019-04-10

1

View

MOTION for Pro Hac Vice Appearance of Attorney Alexander S. Zolan - filed by Merck Sharp & Dohme Corp.. (Attachments: # 1 Certification for Alexander S. Zolan)(Silver, Daniel) (Entered: 04/29/2019)

2019-04-29

1

View

ANSWER to 11 Answer to Complaint, Counterclaim by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 05/01/2019)

2019-05-01

1

View

ORAL ORDER SETTING RULE 16(b) CONFERENCE: A scheduling conference pursuant to Fed. R. Civ. P. 16(b) will be held on Wednesday, June 26, 2019, at 10:00 a.m., in Courtroom 6A of the Boggs Federal Building, 844 King Street, Wilmington, Delaware. Plaintiff's counsel shall coordinate a dial in number for all parties wishing to participate, but not physically being able to do so. The dial in number will be for listening capacity only. The parties shall confer about scheduling and discovery limitations, and attempt to reach agreement. The parties shall use as a basis for discussion the Courts Rule 16 Scheduling Order patent, available on the Courts website. No later than 48 hours before the scheduling conference, the parties shall file a proposed scheduling order using the Rule 16 Scheduling Order - patent. Any requests or questions regarding the scheduling or management of this case shall be directed to the Courts Case Manager at (302) 573-6137. Ordered by Judge Richard G. Andrews on 6/5/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms) (Entered: 06/05/2019)

2019-06-05

1

View

ORAL ORDER: The conference scheduled for 6/26/2019, at 10:00 am will now be held in Courtroom 2B. Ordered by Judge Richard G. Andrews on 6/19/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms) (Entered: 06/19/2019)

2019-06-19

1

View

PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 6/24/2019 (nms). (Entered: 06/24/2019)

2019-06-24

1

View

PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 6/28/2019 (nms). (Entered: 06/28/2019)

2019-06-28

1

View

SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 2/14/2020. Amended Pleadings due by 2/14/2020. Fact Discovery completed by 11/20/2020. Joint Claim Construction Brief due by 7/17/2020. A Markman Hearing is set for 8/18/2020, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 9/10/2021, at 9:00 AM in Courtroom 6A. A 3-day Bench Trial is set to begin 10/4/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 6/28/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms) (Entered: 07/01/2019)

2019-07-01

1

View

NOTICE OF SERVICE of Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents filed by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 07/02/2019)

2019-07-02

1

View

STIPULATION TO EXTEND TIME Exchange of (i) Initial Disclosures pursuant to Rule 26(a); (ii) Paragraph 3 disclosures to July 26, 2019 - filed by Sandoz Inc., Teva Pharmaceutical Industries Ltd., Watson Laboratories, Inc.. (Gattuso, Dominick) (Entered: 07/08/2019)

2019-07-08

1

View

STIPULATION TO EXTEND TIME for submission of a proposed protective order to July 31, 2019 - filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc.. (Mowery, Katharine) (Entered: 07/18/2019)

2019-07-18

1

View

NOTICE OF SERVICE of Plaintiff's Initial Dislcosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery filed by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 07/26/2019)

2019-07-26

1

View

NOTICE OF SERVICE of 1) Sun's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; and 2) Sun's Rule 26(a)(1) Initial Disclosures filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Wilson, Samantha) (Entered: 07/29/2019)

2019-07-29

1

View

STIPULATION TO EXTEND TIME Proposed Protective Order to August 7, 2019 - filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 07/31/2019)

2019-07-31

1

View

NOTICE OF SERVICE of Defendants' production and disclosure pursuant to Paragraphs 3(c)(ii) and 3(d) of the Scheduling Order (D.I. 19) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Wilson, Samantha) (Entered: 08/04/2019)

2019-08-04

1

View

STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Proposed Protective Order to August 15, 2019 - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel) (Entered: 08/06/2019)

2019-08-06

1

View

CERTIFIED TRANSFER ORDER - issued by the Panel on Multi-District Litigation on 8/8/2019 - Associated Cases: 1:19-md-02902-RGA et al.(amf) (Entered: 08/09/2019)

2019-08-08

1

View

NOTICE TO COUNSEL: MDL No. 1:19-md-2902 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents may use the attached form to register for a CM/ECF login and password. Please see the docket for further entries. Associated Cases: 1:19-md-02902-RGA et al.(amf) (Entered: 08/09/2019)

2019-08-08

1

View

STIPULATION TO EXTEND TIME Proposed Protective Order to August 19, 2019 - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel) (Entered: 08/15/2019)

2019-08-15

1

View

PROPOSED Stipulated Protective Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/20/2019 (nms). (Entered: 08/19/2019)

2019-08-19

1

View

SO ORDERED regarding Stipulated Protective Order. Signed by Judge Richard G. Andrews on 8/20/2019. Associated Cases: 1:19-md-02902-RGA et al.(nms) (Entered: 08/21/2019)

2019-08-21

1

View

STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/27/2019 (nms). (Entered: 08/27/2019)

2019-08-27

1

View

NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.'s First Sets of Interrogatories and First Sets of Requests for Production to Defendants filed by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 08/30/2019)

2019-08-30

1

View

STIPULATION and [Proposed] Order by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.. (Wilson, Samantha) (Entered: 09/13/2019)

2019-09-13

1

View

NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 09/13/2019)

2019-09-13

1

View

SO ORDERED Granting (22 in 19-md-2902-RGA; 35 in 19-cv-319-RGA) Stipulation and Proposed Order (*Sun Pharma Global FZE terminated). Signed by Judge Richard G. Andrews on 9/13/2019. Associated Cases: 1:19-cv-00319-RGA, 1:19-md-02902-RGA(nms) (Entered: 09/13/2019)

2019-09-13

1

View

NOTICE OF SERVICE of Defendants' First Set of Joint Interrogatories to Plaintiff (Nos. 1-10) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) (Entered: 09/23/2019)

2019-09-23

1

View

NOTICE OF SERVICE of Defendants' First Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 1-107) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) (Entered: 10/01/2019)

2019-10-01

1

View

NOTICE OF SERVICE of 1) Defendant Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Plaintiff's First Set of Requests for Production and 2) Defendant Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Plaintiff's First Set of Interrogatories filed by Sun Pharmaceutical Industries Ltd..(Wilson, Samantha) (Entered: 10/16/2019)

2019-10-16

1

View

Overview

Parties

Defendant

Sun Pharmaceutical Industries Ltd. Follow

Represented By

Sun Pharma Global FZE Follow

Represented By

Plaintiff

Merck Sharp & Dohme Corp. Follow

Represented By

Court & Judges

Patents Involved

Docket Entries

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) (Entered: 02/14/2019)

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: See Attached. Date of Expiration of Patent: See Attached. (nmg) (Entered: 02/14/2019)

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708; 8,414,921. (nmg) (Entered: 02/14/2019)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (nmg) (Entered: 02/14/2019)

MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Shaun P. Mahaffy, Anthony H. Sheh, and Jingyuan Luo - filed by Merck Sharp & Dohme Corp.. (Attachments: # 1 Certifications)(Silver, Daniel) Modified on 2/22/2019 (nms). (Entered: 02/21/2019)

DECLARATION of Mailing regarding service on Sun Pharma Global FZE made on February 14, 2019, by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibits A-B)(Silver, Daniel) Modified on 2/25/2019 (nms). (Entered: 02/25/2019)

DECLARATION of Mailing regarding service on Sun Pharmaceutical Industries Ltd. made on February 14, 2019, by Merck Sharp & Dohme Corp.. (Attachments: # 1 Exhibits A-B)(Silver, Daniel) Modified on 2/25/2019 (nms). (Entered: 02/25/2019)

STIPULATION TO EXTEND TIME to move against, answer, or otherwise plead in response to the Complaint to April 10, 2019 - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.. (Gaza, Anne) (Entered: 03/07/2019)

MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Claire A. Fundakowski and Zachary B. Cohen - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.. (Wilson, Samantha) (Entered: 03/15/2019)

ANSWER to 1 Complaint, Affirmative Defenses, and COUNTERCLAIMS against Merck Sharp & Dohme Corp. by Sun Pharmaceutical Industries Ltd., Sun Pharma Global FZE.(Gaza, Anne) Modified on 4/10/2019 (nms). (Entered: 04/10/2019)

Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Industries Ltd. for Sun Pharma Global FZE filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.. (Wilson, Samantha) (Entered: 04/10/2019)

MOTION for Pro Hac Vice Appearance of Attorney Alexander S. Zolan - filed by Merck Sharp & Dohme Corp.. (Attachments: # 1 Certification for Alexander S. Zolan)(Silver, Daniel) (Entered: 04/29/2019)

ANSWER to 11 Answer to Complaint, Counterclaim by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 05/01/2019)

ORAL ORDER: The conference scheduled for 6/26/2019, at 10:00 am will now be held in Courtroom 2B. Ordered by Judge Richard G. Andrews on 6/19/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms) (Entered: 06/19/2019)

PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 6/24/2019 (nms). (Entered: 06/24/2019)

PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 6/28/2019 (nms). (Entered: 06/28/2019)

NOTICE OF SERVICE of Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents filed by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 07/02/2019)

STIPULATION TO EXTEND TIME Exchange of (i) Initial Disclosures pursuant to Rule 26(a); (ii) Paragraph 3 disclosures to July 26, 2019 - filed by Sandoz Inc., Teva Pharmaceutical Industries Ltd., Watson Laboratories, Inc.. (Gattuso, Dominick) (Entered: 07/08/2019)

STIPULATION TO EXTEND TIME for submission of a proposed protective order to July 31, 2019 - filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc.. (Mowery, Katharine) (Entered: 07/18/2019)

NOTICE OF SERVICE of Plaintiff's Initial Dislcosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery filed by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 07/26/2019)

NOTICE OF SERVICE of 1) Sun's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; and 2) Sun's Rule 26(a)(1) Initial Disclosures filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Wilson, Samantha) (Entered: 07/29/2019)

STIPULATION TO EXTEND TIME Proposed Protective Order to August 7, 2019 - filed by Sandoz Inc.. (Gattuso, Dominick) (Entered: 07/31/2019)

NOTICE OF SERVICE of Defendants' production and disclosure pursuant to Paragraphs 3(c)(ii) and 3(d) of the Scheduling Order (D.I. 19) filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Wilson, Samantha) (Entered: 08/04/2019)

STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Proposed Protective Order to August 15, 2019 - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel) (Entered: 08/06/2019)

CERTIFIED TRANSFER ORDER - issued by the Panel on Multi-District Litigation on 8/8/2019 - Associated Cases: 1:19-md-02902-RGA et al.(amf) (Entered: 08/09/2019)

STIPULATION TO EXTEND TIME Proposed Protective Order to August 19, 2019 - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel) (Entered: 08/15/2019)

PROPOSED Stipulated Protective Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/20/2019 (nms). (Entered: 08/19/2019)

SO ORDERED regarding Stipulated Protective Order. Signed by Judge Richard G. Andrews on 8/20/2019. Associated Cases: 1:19-md-02902-RGA et al.(nms) (Entered: 08/21/2019)

STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/27/2019 (nms). (Entered: 08/27/2019)

NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.'s First Sets of Interrogatories and First Sets of Requests for Production to Defendants filed by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 08/30/2019)

STIPULATION and [Proposed] Order by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.. (Wilson, Samantha) (Entered: 09/13/2019)

NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel) (Entered: 09/13/2019)

SO ORDERED Granting (22 in 19-md-2902-RGA; 35 in 19-cv-319-RGA) Stipulation and Proposed Order (*Sun Pharma Global FZE terminated). Signed by Judge Richard G. Andrews on 9/13/2019. Associated Cases: 1:19-cv-00319-RGA, 1:19-md-02902-RGA(nms) (Entered: 09/13/2019)

NOTICE OF SERVICE of Defendants' First Set of Joint Interrogatories to Plaintiff (Nos. 1-10) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) (Entered: 09/23/2019)

NOTICE OF SERVICE of Defendants' First Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 1-107) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) (Entered: 10/01/2019)

Track Case Updates

Sun Pharmaceutical Industries Ltd.

Sun Pharma Global FZE

Merck Sharp & Dohme Corp.